Pignata S - Search Results

1

Efficacy of subsequent chemotherapy for patients with BRCA1/2-mutated recurrent epithelial ovarian cancer progressing on olaparib versus placebo maintenance: post-hoc analyses of the SOLO2/ENGOT Ov-21 trial.

Frenel JS, Kim JW, Aryal N, Asher R, Berton D, Vidal L, Pautier P, Ledermann JA, Penson RT, Oza AM, Korach J, Huzarski T, Pignata S, Colombo N, Park-Simon TW, Tamura K, Sonke GS, Freimund AE, Lee CK, Pujade-Lauraine E. Frenel JS, et al. Among authors: pignata s. Ann Oncol. 2022 Oct;33(10):1021-1028. doi: 10.1016/j.annonc.2022.06.011. Epub 2022 Jun 27. Ann Oncol. 2022. PMID: 35772665 Free article. Clinical Trial.

2

Intraperitoneal chemotherapy with carboplatin and recombinant interferon alpha in ovarian cancer.

Ferrari E, Maffeo DA, Graziano R, Gallo MS, Pignata S, De Rosa L, Montella M, Pergola M. Ferrari E, et al. Among authors: pignata s. Eur J Gynaecol Oncol. 1994;15(6):437-42. Eur J Gynaecol Oncol. 1994. PMID: 7875158 Clinical Trial.

3

A phase I study of gemcitabine and epirubicin for the treatment of platinum-resistant or refractory advanced ovarian cancer.

Pignata S, Varriale E, Casella G, Iodice F, De Placido G, Perrone F, Tramontana F, Ricchi P, De Vivo R, Costanzo R, Vernaglia A, Tramontana S. Pignata S, et al. Ann Oncol. 2000 May;11(5):613-6. doi: 10.1023/a:1008344528791. Ann Oncol. 2000. PMID: 10907958 Free article. Clinical Trial.

4

Characterization of 2 novel and 2 recurring BRCA1 germline mutations in breast and/or ovarian carcinoma patients from the area of Naples.

Curci A, Capasso I, Romano A, Bruni P, Motti ML, Pignata S, D'Aiuto G, Casamassimi A, D'Urso M, Fusco A, Viglietto G. Curci A, et al. Among authors: pignata s. Int J Oncol. 2002 May;20(5):963-70. doi: 10.3892/ijo.20.5.963. Int J Oncol. 2002. PMID: 11956590

5

Phase III multicenter randomized trial of amifostine as cytoprotectant in first-line chemotherapy in ovarian cancer patients.

Lorusso D, Ferrandina G, Greggi S, Gadducci A, Pignata S, Tateo S, Biamonte R, Manzione L, Di Vagno G, Ferrau' F, Scambia G; Multicenter Italian Trials in Ovarian Cancer invesitgators. Lorusso D, et al. Among authors: pignata s. Ann Oncol. 2003 Jul;14(7):1086-93. doi: 10.1093/annonc/mdg301. Ann Oncol. 2003. PMID: 12853351 Free article. Clinical Trial.

6

Safety of cisplatin after severe hypersensitivity reactions to carboplatin in patients with recurrent ovarian carcinoma.

Ottaiano A, Tambaro R, Greggi S, Prato R, Di Maio M, Esposito G, Scala F, Barletta E, Losito S, De Vivo R, Iaffaioli VR, Pignata S. Ottaiano A, et al. Among authors: pignata s. Anticancer Res. 2003 Jul-Aug;23(4):3465-8. Anticancer Res. 2003. PMID: 12926091 Clinical Trial.

7

An escalating dose finding study of liposomal doxorubicin and vinorelbine for the treatment of refractory or resistant epithelial ovarian cancer.

Tambaro R, Greggi S, Iaffaioli RV, Rossi A, Pisano C, Manzione L, Ferrari E, Di Maio M, Iodice F, Casella G, Laurelli G, Pignata S. Tambaro R, et al. Among authors: pignata s. Ann Oncol. 2003 Sep;14(9):1406-11. doi: 10.1093/annonc/mdg364. Ann Oncol. 2003. PMID: 12954580 Free article. Clinical Trial.

8

Medical treatment of resistant or recurrent epithelial ovarian cancer.

Pignata S, Pisano C, Di Maio M, Iodice F, Casella G, Laurelli G, Greggi S, Iaffaioli RV. Pignata S, et al. Ann Oncol. 2006 Jun;17 Suppl 7:vii49-50. doi: 10.1093/annonc/mdl950. Ann Oncol. 2006. PMID: 16760292 Free article.

9

Carboplatin and pegylated liposomal doxorubicin for advanced ovarian cancer: preliminary activity results of the MITO-2 phase III trial.

Pignata S, Scambia G, Savarese A, Breda E, Sorio R, Pisano C, Lorusso D, Cognetti F, Vernaglia Lombardi A, Gebbia V, Scollo P, Morabito A, Signoriello G, Perrone F. Pignata S, et al. Oncology. 2009;76(1):49-54. doi: 10.1159/000178760. Epub 2008 Nov 27. Oncology. 2009. PMID: 19039248 Clinical Trial.

10

Evaluation of pemetrexed (Alimta, LY231514) as second-line chemotherapy in persistent or recurrent carcinoma of the cervix: the CERVIX 1 study of the MITO (Multicentre Italian Trials in Ovarian Cancer and Gynecologic Malignancies) Group.

Lorusso D, Ferrandina G, Pignata S, Ludovisi M, Viganò R, Scalone S, Scollo P, Breda E, Pietragalla A, Scambia G. Lorusso D, et al. Among authors: pignata s. Ann Oncol. 2010 Jan;21(1):61-6. doi: 10.1093/annonc/mdp266. Epub 2009 Jul 15. Ann Oncol. 2010. PMID: 19605508 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

453 results

Search Page